Auxilium On a Roll ...
Health Care: Drugs
Endo Pharmaceutical Holdings Inc. (ENDP: NASDAQ)
$30.87 -0.45 | -1.44%
06/04/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 2.73B | 1.72B | 1.46B | 1.26B |
| Cost of Sales | 795.01M | 374.34M | 275.17M | 217.33M |
| Gross Operating Profit | 1.94B | 1.34B | 1.19B | 1.04B |
| Selling, General, and Administrative Expenses | 824.53M | 547.60M | 441.44M | 488.06M |
| Research & Development | 182.29M | 144.52M | 185.32M | 110.21M |
| Operating Income before D & A (EBITDA) | 928.30M | 649.76M | 558.91M | 444.93M |
| Depreciation & Amortization | 270.20M | 130.42M | 99.88M | 49.90M |
| Interest Income | 599.00K | 1.36M | 0.00 | 24.83M |
| Other Income - Net | -42.29M | -17.04M | 7.35M | -1.75M |
| Special Income / Charges | -116.09M | -35.00M | -69.00M | -8.08M |
| Total Income Before Interest Expenses (EBIT) | 500.31M | 468.65M | 397.38M | 410.55M |
| Interest Expense | 148.62M | 47.96M | 37.72M | 8.35M |
| Pre-Tax Income | 351.69M | 420.70M | 359.66M | 402.20M |
| Income Taxes | 109.63M | 133.68M | 93.32M | 140.46M |
| Minority Interest | 54.45M | 28.01M | 0.00 | 0.00 |
| Net Income From Continuing Operations | 187.61M | 259.01M | 266.34M | 261.74M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 187.61M | 259.01M | 266.34M | 261.74M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 187.61M | 259.01M | 266.34M | 261.74M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
303.70M | 294.01M | 335.34M | 269.29M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 187.61M | 259.01M | 266.34M | 261.74M |
| Basic EPS from Continuing Ops. | 1.61 | 2.23 | 2.27 | 2.12 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 1.61 | 2.23 | 2.27 | 2.12 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 1.61 | 2.23 | 2.27 | 2.12 |
| Basic Normalized Net Income/Share | 2.61 | 2.53 | 2.86 | 2.18 |
| EPS fr Continuing Ops. | 1.55 | 2.20 | 2.27 | 2.12 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 1.55 | 2.20 | 2.27 | 2.12 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 1.55 | 2.20 | 2.27 | 2.12 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
2.51 | 2.50 | 2.86 | 2.18 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ENDP
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ProLee Ainslie - Maverick Capital
- ProD.E. Shaw
- ContributorTechnical Setups for the We...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ProChuck Royce - Royce & Assoc...
- ProJohn Hussman
- ContributorTechnical Setups for the We...
- ProZebra Capital
Latest ENDP Headlines from TheStreet
- 7 Stocks Surging on Big Volume 05.29.12 | 01:05 pm
- Downgrades Roundup: SPX, Avon, Shutterfly 05.07.12 | 07:05 am
- Endo Pharmaceutical Holdings Inc. Stock Downgraded (ENDP) 05.03.12 | 05:05 am
- Endo Pharmaceuticals Holdings' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.01.12 | 03:05 pm
- Endo Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.24.12 | 12:02 pm
- BioSante: A Penny Stock Still Overvalued 02.16.12 | 07:02 am
- UBS: 6 Specialty Pharma Picks to Watch 01.21.12 | 07:01 am
- Endo Pharmaceutical Holdings Inc. (ENDP): Today's Featured Health Care Winner 12.12.11 | 04:12 pm
- 7 Stocks Rising on Unusual Volume 12.12.11 | 12:12 pm
- Endo Pharmaceuticals At 2011 Credit Suisse Annual Health Care Conference Call Transcript 11.11.11 | 02:11 pm
Press Releases for ENDP
- Endo Announces Resolution Of Patent Litigation With Watson Pharmaceuticals Related To Lidoderm® - PR Newswire 05.29.12 | 07:05 am
- Endo Health Solutions Inc. To Present At Jefferies 2012 Global Healthcare Conference - PR Newswire 05.25.12 | 01:05 pm
- Endo Health Solutions Inc. To Present At The Goldman Sachs 33rd Annual Global Healthcare Conference - PR Newswire 05.25.12 | 01:05 pm
- Endo Health Solutions Inc. Announced As New Name For Endo Pharmaceuticals Holdings Inc. - PR Newswire 05.23.12 | 02:05 pm
- Endo Pharmaceuticals To Announce First Quarter 2012 Financial Results On May 1, 2012 - PR Newswire 04.17.12 | 09:04 am
- Qualitest Pharmaceuticals Receives FDA Approval For Levetiracetam Oral Solution, 100 Mg/mL - PR Newswire 04.12.12 | 04:04 pm
- Endo Announces Departure Of American Medical Systems President - PR Newswire 03.29.12 | 01:03 pm
- Endo Acquires Johnson Matthey's Oxymorphone Patent - PR Newswire 03.22.12 | 08:03 am
- BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of Its Annual Report - PR Newswire 03.19.12 | 04:03 pm
- Endo Files Amended Citizen Petition Seeking Public FDA Resolution Of Several Safety And Efficacy Issues Prior To Approval Of A Generic Formulation Of LIDODERM® - PR Newswire 03.13.12 | 08:03 am
Partner Headlines for ENDP
- UNVEILED: Analyst Share Price Targets Wednesday - Wall St. Cheat Sheet 05.30.12 | 04:05 am
- Healthcare Biz Recap: HGSI Shareholder Sues, Endo Health Kisses Watson Pharma - Wall St. Cheat Sheet 05.29.12 | 11:05 am
- Auxilium-Glaxo to Drive Testim Sales - Analyst Blog - Zacks 05.22.12 | 10:05 am
- UPDATE: Citigroup Rates Endo Pharmaceuticals as Buy, $48 TP - Benzinga 03.26.12 | 12:03 pm
- BioDelivery Sciences Provides Business Review - Benzinga 03.19.12 | 04:03 pm
- VIX - Options Volatility Sonar: Friday Recap - Seeking Alpha 03.09.12 | 04:03 pm
- Earnings Beat at Endo Pharma - Analyst Blog - Zacks 02.28.12 | 09:02 am
- Stocks To Watch This Week - Seeking Alpha 01.10.12 | 08:01 am
- Billionaire David Shaw's Favorite Stock Picks - Seeking Alpha 12.15.11 | 09:12 am
- Nupathe's Zelrix Going Down A Path With Multiple Headwinds - Seeking Alpha 12.09.11 | 09:12 am
